Company Quick10K Filing
Solbright
10-Q 2019-11-30 Filed 2020-01-22
10-Q 2019-08-31 Filed 2019-10-15
10-K 2019-05-31 Filed 2019-09-13
10-Q 2019-02-28 Filed 2019-05-20
10-Q 2018-11-30 Filed 2019-04-15
10-Q 2018-08-31 Filed 2018-10-19
10-K 2018-05-31 Filed 2018-09-18
10-Q 2018-02-28 Filed 2018-04-20
S-1 2018-02-27 Public Filing
10-Q 2017-11-30 Filed 2018-01-16
10-Q 2017-08-31 Filed 2017-10-24
10-K 2017-05-31 Filed 2017-09-14
10-Q 2017-02-28 Filed 2017-04-21
10-Q 2016-11-30 Filed 2017-01-23
10-Q 2016-08-31 Filed 2016-10-17
10-K 2016-05-31 Filed 2016-09-21
10-Q 2016-02-29 Filed 2016-04-20
10-Q 2015-11-30 Filed 2016-01-19
10-Q 2015-08-31 Filed 2015-10-15
10-K 2015-05-31 Filed 2015-08-27
10-Q 2015-02-28 Filed 2015-04-14
10-Q 2014-11-30 Filed 2015-01-14
10-Q 2014-08-31 Filed 2014-10-14
10-K 2014-05-31 Filed 2014-08-27
10-Q 2014-02-28 Filed 2014-04-14
10-Q 2013-11-30 Filed 2014-01-15
10-Q 2013-08-31 Filed 2013-10-11
10-Q 2013-02-28 Filed 2013-09-16
10-Q 2012-11-30 Filed 2013-09-13
10-Q 2012-08-31 Filed 2013-09-12
10-K 2012-05-31 Filed 2013-08-30
10-Q 2011-02-28 Filed 2011-04-19
10-Q 2010-11-30 Filed 2011-01-12
10-Q 2010-08-31 Filed 2010-10-19
10-K 2010-05-31 Filed 2010-09-14
10-Q 2010-02-28 Filed 2010-04-02
8-K 2020-08-31
8-K 2020-06-30
8-K 2020-05-08
8-K 2020-05-04
8-K 2020-04-24
8-K 2020-04-14
8-K 2020-03-04
8-K 2019-12-31
8-K 2019-12-09
8-K 2019-11-15
8-K 2019-05-20
8-K 2019-03-07
8-K 2019-01-08
8-K 2018-11-26
8-K 2018-10-31
8-K 2018-10-01
8-K 2018-09-05
8-K 2018-07-30
8-K 2018-06-28
8-K 2018-05-31
8-K 2018-04-30

Solbright Financials

SBRT Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Cash511809234512631143119123010235291263956621110470827226114726891,311789
Accounts Receivable3020221326113420919222322121,0861,0891,0041,98716184548582507
Inventory157344294971201418162000
PP&E88877727262423222013,92313,98713,884
Assets511809234516132365130127217553872750338358552343024419,01619,17318,23618,87915,67015,03119,87321,83112,978
Accounts Payable1,4881,5031,5046436192963913963873754974647018327507839218146482,1472,7693,0583,7773,7772,98412,38610,28314,136
Long-Term Debt6001404084661,2491,4490004574574574572,0002,0002,0002,00017975,22777,119
Liabilities9,2979,3449,3749,4179,5549,6969,4019,6304,2513,2783,3383,1573,7882,1302,1491,9262,1392,3642,3872,02713,00315,3279,84910,81811,2516,38398,575103,103107,736
Stockholders' Equity-9,292-9,344-9,194-9,324-9,209-9,535-9,078-9,565-4,121-3,152-3,317-3,082-3,250-1,402-1,646-1,544-1,554-1,841-1,958-1,7836,0133,8468,3868,0614,4198,647-78,702-81,272-94,758
Income Statement ($'000)2012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Revenue0000000401191422231078157492004243902741,2695,2783,2912,4978457431,892
Cost of Revenue000000005353723380267519704,4963,6891,5691,5771,0356991,028737
Gross Profit0000000028037719744131212299782-398928-581-19045864-1,118
R&D000374161057552886013298186272794114400302681,4411,366
SG&A40161091932224372771,3011,1871,1645752,2365297812822,1103136243052,3121,5781,5501,5352,9741,7634,7292,8844,241
Tax000000000-360000000121-1200000000
Net Income-51-30-151-285-325-549-48762,5511,300200-597-2,293-529-69561-1,947-287-509-272-2,280-3,809-2,897-2,442-6,657-5,057-17,180-13,604-17,451
Cash Flow ($'000)2012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Cash Operating6-108-219-216-267-195-123-30-235-447-25631-3-20152-349-730730-36338-2,370-5,599-2,499
Cash Investing000000-190-3,000-5-5000-13-109
Cash Financing-10200400020004046050300201501641484,189-368347702,3286,2342,085